The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents: Drug combination against C. albicans
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Combination therapy can be used for the treatment of fungal infections, especially for those caused by antifungal-resistant fungi. In the present study, in vitro interactions and mechanisms between fluconazole and minocycline against Candida albicans were evaluated. The nature of the interactions determined by spectrophotometric method in a checkerboard assay was interpreted using nonparametric models of fractional inhibitory concentration index (FICI) and percentages of growth difference (ΔE). In the mechanism study, we evaluated the potential activity of minocycline on fluconazole penetrating the C. albicans biofilm. Furthermore, the effect of fluconazole and minocycline alone and in combination on the cellular calcium balance, as well as on the uptake and efflux of fluconazole were evaluated. It was found that fluconazole can work synergistically with minocycline against fluconazole-resistant C. albicans; the minimum inhibitory concentration of fluconazole decreased from 512 to 2 microgmL(-1) when fluconazole and minocycline were given in combination, with an FICI of 0.035 and 0.064 and high-percentage synergistic interactions of 1250% and 988% for the two resistant strains. The mechanism of action was suggested to be the enhancement of minocycline on fluconazole penetrating biofilm, and inducing the intracellular calcium release, instead of impacting on the uptake and efflux of fluconazole. Our results suggest that the combination of fluconazole and minocycline can reduce the fluconazole resistance of C. albicans in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 1×
“Several studies have estimated that 6–11% of all positive nosocomial bloodstream infections could be attributed to Candida spp. (Wisplinghoff et al., 2004; Pfaller & Diekema, 2007).”
BackgroundEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“Several studies have estimated that 6–11% of all positive nosocomial bloodstream infections could be attributed to Candida spp. (Wisplinghoff et al., 2004; Pfaller & Diekema, 2007).”
BackgroundChandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578 · cited 2×
“…majority of clinical cases of antifungal resistance have been reported for the class of azoles (Sanglard, 2003), and fungal biofilm-associated infections are frequently refractory to conventional therapy because of resistance to antimicrobial agents (Chandra et al., 2001; Donlan & Costerton, 2002).”
BackgroundAnderl, J. N., Franklin, M. J., & Stewart, P. S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1818-1824.2000 · Cited by 958 · cited 1×
“Although there have been many reports on the phenomenon of incomplete penetration of antimicrobial agents through bacterial biofilms (Suci et al., 1994; Anderl et al., 2000; Stewart & Costerton, 2001; Zheng & Stewart, 2002), few have investigated this particular feature in Candida biofilms.”
BackgroundEpidemiology of invasive candidiasis
Arendrup, M. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e84d2 · Cited by 376
Regulation of multidrug resistance in pathogenic fungi
Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300 · cited 2×
“It is likely that multiple mechanisms are involved in drug resistance, of which the overexpression of efflux pumps is considered a major mechanism (Rogers, 2002; Morschhäuser, 2010).”
BackgroundOnyewu, C., Blankenship, J. R., Del Poeta, M., & Heitman, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.956-964.2003 · Cited by 282
Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candidaalbicans strains
Maesaki, S., Marichal, P., Bossche, H. V., Sanglard, D., & Kohno, S. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.1.27 · Cited by 162
Antifungal Combinations against Candida albicans Biofilms In Vitro
Bachmann, S. P., Ramage, G., VandeWalle, K., Patterson, T. F., Wickes, B. L., & López-Ribot, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3657-3659.2003 · Cited by 89
Cited by
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422
Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans
Liu, S., Yue, L., Gu, W., Li, X., Zhang, L., & Sun, S. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150859 · Cited by 87
“Statistically significant interactions of<100% were considered weak, those of 100– 200% were considered moderate, and those of>200% were considered strong, as described previously [33].”
BackgroundSelf-citationGu, W., Guo, D., Zhang, L., Xu, D., & Sun, S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03046-15 · Cited by 80
Self-citationThe role of antifungals against Candida biofilm in catheter-related candidemia
Bouza, E., Guinea, J., & Guembe, M. (2014) · Antibiotics · doi:10.3390/antibiotics4010001 · Cited by 62
“albicans, probably owing to the boosting of fluconazole by minocycline as it penetrates biofilm [59].”
BackgroundSavage, K. A., Parquet, M. D. C., Allan, D. S., Davidson, R. J., Holbein, B. E., Lilly, E. A., & Fidel, P. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02576-17 · Cited by 53
“(35) proposed that minocycline enhances FLC penetration due to Ca efflux, while Fiori and Van Dijck (32) concluded that doxycycline enhancement of FLC was related to its iron-binding activity.”
Background
Metadata
- Authors
- Shi, W., Chen, Z., Chen, X., Cao, L., Liu, P., & Sun, S.
- Venue
- FEMS Yeast Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-08-12
- Volume
- 10
- Issue
- 7
- Pages
- 885-893
- ISSN
- 1567-1356 (ISSN-L)
- OpenAlex
- W1837857222
- Cited by
- 71
- References
- 9
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents: Drug combination against C. albicans. https://app.cochat.ai/papers/10.1111/j.1567-1364.2010.00664.x
- The paper
- Shi, W., Chen, Z., Chen, X., Cao, L., Liu, P., & Sun, S. (2010). The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents: Drug combination against C. albicans. FEMS Yeast Research. https://doi.org/10.1111/j.1567-1364.2010.00664.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.